Headlines

---

Recent Headlines

	Keep an Eye on Allergies This Season	Johnson & Johnson Press Releases
	Jacksonville, FL (April 17, 2008) ? An estimated 50 million Americans suffer from the miseries of allergies, with allergic reactions involving the eyes a common complaint. For many, symptoms of eye allergies can be so uncomfortable and irritating that they interfere with job performance, impede leisure-time and sports activities, and curtail vacations.To help allergy sufferers better understand and manage the condition, the Asthma and Allergy Foundation of America (AAFA), the leading patient organizat ...
	CLEAN & CLEAR® Introduces SOFT	Johnson & Johnson Press Releases
	Skillman, NJ (April 15, 2008)? Consumer studies have shown that 84% of females aged 18 ? 24 began using a facial moisturizer before they turned 18, which is a telling sign that young women today are very concerned with their skincare regimen.1 There are an abundance of facial skincare products for young consumers on the market today, but most address acne and problem skin, rather than offering a healthy daily regimen for normal skin. For those young consumers who do not suffer from acne, the skincare ...
	First-Quarter 2008 Financial Results	Johnson & Johnson Press Releases
	New Brunswick, NJ (April 15, 2008) ? Johnson & Johnson today announced record sales of $16.2 billion for the first quarter of 2008, an increase of 7.7% as compared to the first quarter of 2007. Operational growth was 2.6% and currency contributed 5.1%. Domestic sales were up 2.8%, while international sales increased 13.7%, reflecting operational growth of 2.4% and a positive currency impact of 11.3%. Net earnings and diluted earnings per share for the first quarter of 2008 were $3.6 billion and ...
	Positive SAPPHIRE Study Published in NEJM	Johnson & Johnson Press Releases
	Warren, NJ (April 9, 2008) ? According to a study published in The New England Journal of Medicine this week, three-year data from the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) study in patients with severe blocked carotid arteries, the main blood vessels in the neck leading to the brain, who underwent carotid artery stenting (CAS) with the PRECISE® Nitinol Stent and the ANGIOGUARD® Emboli Capture Guidewire were comparably protected from stroke, he ...
	Therakos, Inc. Receives CE Mark in Europe	Johnson & Johnson Press Releases
	Ascot, UK (April 14, 2008) ? Therakos, Inc., a pioneer for more than 20 years in immune cell therapy, announced receipt of a CE Mark in Europe for THERAKOST? CELLEXT? Photopheresis System, a therapy for the treatment of patients with immune-mediated diseases such as acute or chronic graft-versus-host disease (GvHD) and cutaneous T-cell lymphoma (CTCL). THERAKOS? CELLEX? Photopheresis System is the next generation in a product line that offers the only validated, automated and integrated systems that a ...
	OneTouch® Laugh & Learn Sweepstakes Award Scholar...	Johnson & Johnson Press Releases
	Milpitas, CA (April 11, 2008) ? LifeScan, a Johnson & Johnson company and the maker of OneTouch® Blood Glucose Meters for people with diabetes, has announced an online sweepstakes that will offer an opportunity for kids with diabetes to attend a diabetes camp for free this summer. The OneTouch® Laugh & Learn Sweepstakes, which runs through May 20, is available at www.DiabetesAndKids.com and offers 30 Grand-Prize winners a weeklong stay at a diabetes camp1 of their choice, selected from a list of camps ...
	ORD To Present Data At Cancer Meeting	Johnson & Johnson Press Releases
	San Diego, CA (April 11 2008) ? Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will announce results from studies of three innovative compounds?Hdm2, c-Met, and HDAC inhibitors?here at the American Association for Cancer Research (AACR) 2008 Annual Meeting."ORD is a new research and development organization that unites the biotechnology and pharmaceutical oncology efforts of several Johnson & Johnson companies with the go ...